Skip to main content
. 2014 Sep 29;23(6):186–199. doi: 10.1007/s40629-014-0022-4

Table 3.

Complete overview of evaluated studies according to number and study type, the evidence levels derived, and consensus-based levels of recommendation according to topic

Area Number and type of study Evidence levels Recommendation levels
Breastfeeding 0 MA, 1 RCT, 7 CS, 0 CC, 3 CSS 1x1b, 7x2b A
Maternal diet during pregnancy and/or lactation 0 MA, 5 RCT, 15 CS, 0 CC, 0 CSS 5x1b, 15x2b A and B
Breast-milk substitutes in at-risk infants 0 MA, 2 RCT, 2 CS, 0 CC, 0 CSS 2x1b, 2x2b A
Introduction of solid foods and infant diet up to the age of 1 year 1 MA, 2 RCT, 8 CS, 3 CC, 5 CSS 2x1b, 8x2b, 3x3b A and B
Diet after the age of 1 year and body weight 2 SR, 0 RCT, 4 CS, 2 CC, 7 CSS 4x2b, 2x3b A
General diet and vitamin D: during pregnancy/lactation and up to the age of 1 year 2 SR, 1 RCT, 4 CS, 3 CC, 4 CSS 1x1b, 2x2b, 3x3b -
Effects of probiotics and prebiotics 3 SR, 15 RCT, 1 CS, 1 CC, 0 CSS 15x1b, 1x2b -
Keeping pets 2 SR, 0 RCT, 3 CS, 0 CC, 1 CSS 3x2b B
House dust mites 0 MA, 0 RCT, 3 CS, 1 CC, 2 CSS 3x2b, 1x3b A
Mold and dampness 3 MA, 0 RCT, 3 CS, 1 CC, 0 CSS 3x2a, 3x2b, 2x3b B
Exposure to tobacco smoke 0 MA, 0 RCT, 2 CS, 0 CC, 1 CSS 2x2b A
Vaccination 0 MA, 1 RCT, 1 CS, 0 CC, 2 CSS 1x1b, 1x2b A
Motor vehicle emissions 0 MA, 1 RCT, 0 CS, 0 CC, 3 CSS 4x2b, 2x3b B
Non-specific immune modulation 1 SR, 0 RCT, 4 CS, 0 CC, 5 CSS 4x2b -
Pharmaceutical drug use 1 SR, 1 RCT, 4 CS, 1 CC, 5 CSS 1x1b, 4x2b, 1x3b -
Psychological factors 0 SR, 0 RCT, 1 CS, 0 CC, 1 CSS 1x2b -
Childbirth 1 SR, 0 RCT, 2 CS, 0 CC, 1 CSS 2x2b -
In total 12 SR, 4 MA, 29 RCT, 64 CS, 12 CC, 4 CSS 28x1b, 3x2a, 66x2b, 14x3b -

CC, case-control study; CS, cohort study; MA, meta-analysis; RCT, randomized controlled study; SR systematic review; CSS, cross-sectional study